Trials / Completed
CompletedNCT01672645
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
A Phase 1, Randomized, Double Blind, Placebo Controlled Study To Evaluate The Safety, Tolerability, Immunogenicity, And Exploratory Efficacy Of Multiple Ascending Dose Levels Of Pf-05402536 And Pf-06413367 In Healthy Adult Smokers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 277 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and tolerability of multiple doses of PF-05402536 and PF-06413367 in healthy adult smokers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | NIC7-001 | Intramuscular, multiple dose |
| BIOLOGICAL | NIC7-003 | Intramuscular, multiple dose |
| BIOLOGICAL | Saline | Saline (0.9% sodium chloride) |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2012-08-27
- Last updated
- 2016-01-26
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01672645. Inclusion in this directory is not an endorsement.